Citius Pharmaceuticals (CTXR) Shares Outstanding (Diluted) (2010 - 2026)
Citius Pharmaceuticals (CTXR) recorded Shares Outstanding (Diluted) of 26.17 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 137.8% from 11.01 million a year earlier and up 17.0% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Shares Outstanding (Diluted) of 11.07 million, up 64.5% from FY2024.
- Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of 55.9% (FY2020 to FY2025).
- Across earlier fiscal years, Shares Outstanding (Diluted) came in at 6.73 million in FY2024 (-95.6%), 151.29 million in FY2023 (+3.6%), 146.08 million in FY2022 (+34.5%) and 108.6 million in FY2021.
- The fiscal Q3 2026 figure is the highest quarterly Shares Outstanding (Diluted) since fiscal Q3 2024.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for four consecutive quarters, with growth averaging 21.3% over the last eight quarters.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 186.9% in fiscal Q1 2026, against a decline of 95.6% in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 22.38 million (Q2 2026), 21.5 million (Q1 2026) and 11.07 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Citius Pharmaceuticals | 9.70 Mn | -23.87 Mn | 1.00 Mn | 26.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.17 Mn |
| Mar 31, 2026 | 22.38 Mn |
| Dec 31, 2025 | 21.50 Mn |
| Sep 30, 2025 | 11.07 Mn |
| Jun 30, 2025 | 11.01 Mn |
| Mar 31, 2025 | 8.58 Mn |
| Dec 31, 2024 | 7.49 Mn |
| Sep 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 173.86 Mn |
| Mar 31, 2024 | 159.07 Mn |
| Dec 31, 2023 | 158.96 Mn |
| Sep 30, 2023 | 151.29 Mn |
| Jun 30, 2023 | 153.78 Mn |
| Mar 31, 2023 | 146.25 Mn |
| Dec 31, 2022 | 146.21 Mn |
| Sep 30, 2022 | 146.08 Mn |
| Jun 30, 2022 | 146.13 Mn |
| Mar 31, 2022 | 146.04 Mn |
| Dec 31, 2021 | 146.01 Mn |
| Sep 30, 2021 | 108.60 Mn |
API Access
Citius Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();